FTSE 100 movers: Miners fall; Rentokil higher after Trian buys shares
London's FTSE 100 was down 0.3% at 8,284.13 in afternoon trade on Friday.
Miners Anglo, Rio and Glencore were among the worst performers as copper prices fell.
Rentokil Initial sparked after activist investor Nelson Peltz's Trian Fund Management bought 7.5m shares in the pest control company for £31m.
The shares were purchased at 413.4p each on 11 December.
Trian took a 2.26% stake in Rentokil in June and in September, the company announced the appointment of a representative of Trian to its board as a non-executive director, sending the shares surging.
Diageo was also a high riser. On Thursday, UBS upgraded shares of the drinks maker to 'buy' from 'sell' and hiked the price target to 2,920p from 2,300p, saying it sees upside risks to the US business.
"Our analysis shows its sell-out trends are running +3.6%, significantly outperforming a still weak Spirits industry, and the strong growth momentum behind key brands Don Julio and Crown Royal can be sustained," UBS said.
"Following -31% earnings per share downgrades over the past two years, we think investors can gain comfort the business is towards the end of its earnings downgrade cycle."
FTSE 100 - Risers
Rentokil Initial (RTO) 413.60p 3.69%
Beazley (BEZ) 832.50p 2.08%
Diageo (DGE) 2,602.50p 1.72%
Pershing Square Holdings Ltd NPV (PSH) 3,942.00p 1.28%
Marks & Spencer Group (MKS) 394.80p 1.18%
Hiscox Limited (DI) (HSX) 1,140.00p 1.15%
Pearson (PSON) 1,284.50p 1.10%
Smith (DS) (SMDS) 544.00p 0.93%
F&C Investment Trust (FCIT) 1,142.00p 0.88%
Associated British Foods (ABF) 2,144.00p 0.85%
FTSE 100 - Fallers
JD Sports Fashion (JD.) 100.15p -1.81%
Anglo American (AAL) 2,477.50p -1.78%
Fresnillo (FRES) 668.00p -1.69%
Rio Tinto (RIO) 4,922.00p -1.56%
Prudential (PRU) 652.60p -1.54%
Melrose Industries (MRO) 549.80p -1.50%
Spirax Group (SPX) 7,280.00p -1.36%
Croda International (CRDA) 3,445.00p -1.32%
Persimmon (PSN) 1,261.50p -1.25%
Glencore (GLEN) 373.25p -1.23%
Disclaimer & Declaration of Interest
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.